JPRN-UMIN000005506已完成2 期
Efficacy and safety of a triple antiemetic combination with palonosetron, dexamethasone and aprepitant in patients receiving multiple-day cisplatin-containing chemotherapy. - Efficacy and safety of a triple antiemetic combination in patients receiving multiple-day cisplatin-containing chemotherapy.
Graduate School of Medicine and Public Health, Kyoto University0 个研究点目标入组 30 人开始时间: 2011年4月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients have primary or secondary brain and/or intestinal cancer. (2) History of hypersensitivity to any drugs included in the protocol therapy. (3) Patients developing vomiting or retching within 24 hours prior to beginning chemotherapy. (4) Patients receiving antiemetic agents including benzodiazepines within 48 hours prior to beginning chemotherapy. (5) Patients during treatment with pimozide. (6) Patients receiving at least one drug in the following drugs : macrolide antibiotics, azole antifungal agents, barbiturates, warfarin, phenytoin, diltiazem, midazolam, tolbutamide, hormonal contraceptives, HIV protease inhibitors. (7) Patients considered to be ineligible for this study by physicians.
研究者
相似试验
已完成
2 期
Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.patients with gynecological malignancies who are receiving paclitaxel/carboplatin.JPRN-UMIN000007491ara Medical University80
已完成
3 期
The efficacy of combination antiemetic therapy with Olanzapine, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving Moderately Emetogenic Chemotherapygastric cancer, colorectal cancerJPRN-UMIN000034383Osaka Medical Collage150
已完成
不适用
Comparison of antiemetic effectiveness and safety of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer receiving combination therapy with carboplatin: A phase II randomized studylung cancerJPRN-UMIN000010056Hamamatsu University School of Medicine80
招募中
不适用
Comparitive study of two antiemetic drugs group to decrease the chances of emesis after Laproscopic CholecyestectomyCTRI/2018/07/014830Dr RPGMC TANDA84
已完成
4 期
Efficacy and safety of concomitant use of three immunosuppressant therapy for anti-MDA5 antibody-positive dermatomyositis with interstitial pneumoniadermatomyositis with interstitial pneumoniaJPRN-UMIN000014344Kyoto University Graduate School of Medicine25